-91.
111. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network metaanalysis. Cochrane Database Syst Rev 2013:Cd009329.
112. Bibbins-Domingo K. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services
Task Force Recommendation Statement. Ann Intern Med 2016;164:
836-45.
113. Cote R, Battista RN, Abrahamowicz M, Langlois Y, Bourque F,
Mackey A. Lack of effect of aspirin in asymptomatic patients with
carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group. Ann Intern Med 1995;123:649-55.
114. King A, Shipley M, Markus H. The effect of medical treatments on
stroke risk in asymptomatic carotid stenosis. Stroke 2013;44:542-6.
115. Park JM, Kang K, Cho YJ, Hong KS, Lee KB, Park TH, et al.
Comparative effectiveness of prestroke aspirin on stroke severity
and outcome. Ann Neurol 2016;79:560-8.
116. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al.
Guidelines for prevention of stroke in patients with ischemic stroke
or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke
Association Council on Stroke: co-sponsored by the Council on
Cardiovascular Radiology and Intervention: the American Academy
of Neurology afÔ¨Årms the value of this guideline. Stroke 2006;37:
577-617.
117. Collaborative meta-analysis of randomised trials of antiplatelet
therapy for prevention of death, myocardial infarction, and stroke in
high risk patients. BMJ 2002;324:71-86.
118. Albers GW, Amarenco P, Easton